OTTAWA, Oct. 21, 2014 /CNW/ - The field of regenerative medicine – harnessing the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs – is the focus of the Till & McCulloch Meetings, a three-day event being hosted for the first time in Ottawa. Nearly 500 stem cell and regenerative medicine experts representing Canadian and international research groups will come together to share some of the leading advances in research, clinical translation and commercialization within the field. Media are encouraged to attend.
The Meetings, co-hosted by the Stem Cell Network and the Centre for Commercialization of Regenerative Medicine (CCRM), will take place from October 27-29, 2014. The agenda, featuring speakers and their talks, is available here.
Highlighted speakers include:
Dr. John Dick, Princess Margaret Hospital, "Stem cells in cancer: Do they matter?" on Monday, October 27 at 8:45 a.m.
Dr. Aaron Schimmer, University Health Network, "New therapeutic strategies targeting leukemia stem cells" on Monday, October 27 at 3:50 p.m.
Professor Timothy Caulfield, University of Alberta, "Stem cell research and the drive to commercialize: Balancing risks and benefits" on Tuesday, October 28 at 2:00 p.m.
What: 2014 Till & McCulloch Meetings, Canada's premier stem cell research event
Where: Westin Ottawa, 11 Colonel By Drive, 613-560-7000
When: October 27-29, 2014
SOURCE: Stem Cell Network
For further information: Lisa Willemse, Director of Communications, Stem Cell Network, 613-304-2108, [email protected]; Stacey Johnson, Director of Communications, CCRM, 647-309-1830, [email protected]